三来一补：美国占两头，中国搞中间步骤。只不过，这次的分工合作，中国占据了更多的价值链和原创技术

if US deemed it inappropriate of China giving technology for free as AUTHORITARIAN state, us can always give technology for free as a DEMOCRATIC state. And that would be highly appreciated by the world. The thing is, they don't

come to have a deeper look at crinetics #crinetics beyondspx.com/article/crinet…

100 plus sites and hundres of investigators participated the Investigator kick off meeting. That;s a lot of physicians here. Even with a required sample size of 800, the enrollment would be really quick.

first ever targeted therapy for ss for so many years

the re org is long overdued

seems interesting techcommunity.microsoft.com/blog/microsoft…

the right way

pov

摸着东大过河

the right one

a huge market

Potential great news. If liver stiffness measurement could serve as surrogate endpoint for clinical liver events

Idorsia endothelin antagonist approved by FDA for treating difficult-to-treat hypertension, the first of this class Idorsia Pharmaceuticals US Inc. uk.finance.yahoo.com/news/idorsia-t…

irrelavant drug. In China already has liraglutide generic approved and they are not selling any much

this real world short term study results has to be interpreted very cautiously

Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management - The Lancet Diabetes & Endocrinology thelancet.com/journals/landi…

when will be the approval of first generic semaglutide

I asked gemini to draft rhTSH market report in China. And here is the infographic, very interesting and easy to understand. g.co/gemini/share/5…

The story of discovering baxdrostat, a specific aldosterone synthesis inhibitor g.co/gemini/share/1…